Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 20/20 | 1.00 |
| ▸ | S1PR3 | Q99500 | 14/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1601581 | 0.92 | S1PR1 (1.00) | S1PR1S1PR3DRD3 | |
| SCHEMBL1601422 | 0.84 | S1PR1 (1.00) | S1PR1S1PR3DRD3 | |
| SCHEMBL3692568 | 0.82 | S1PR1 (0.82) | S1PR1S1PR3DRD3 | |
| SCHEMBL16143901 | 0.81 | S1PR1 (0.80) | S1PR1S1PR3DRD3 | |
| SCHEMBL2409342 | 0.80 | S1PR1 (0.90) | S1PR1S1PR3DRD3 | |
| SCHEMBL1602813 | 0.78 | S1PR1 (0.75) | S1PR1S1PR3DRD3 | |
| SCHEMBL1661439 | 0.77 | S1PR1 (0.81) | S1PR1S1PR3DRD3 | |
| SCHEMBL1661436 | 0.77 | S1PR1 (1.00) | S1PR1S1PR3DRD3 | |
| SCHEMBL16143922 | 0.77 | S1PR1 (0.71) | S1PR1S1PR3DRD3 | |
| SCHEMBL1664101 | 0.77 | S1PR1 (0.78) | S1PR1S1PR3DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545890-B2 | Compositions and methods for derivation of trophoblast stem cells | NORTH CAROLINA STATE UNIVERSITY (US) | 2026-02-10 | — | — | US | claimed |
| US-20250144081-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-08 | — | — | US | claimed |
| US-20250136932-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY | 2025-05-01 | — | — | US | claimed |
| WO-2023150572-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-08-10 | — | — | WO | claimed |
| WO-2023147001-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-08-03 | — | — | WO | claimed |
| US-20220412957-A1 | METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2022-12-29 | — | — | US | claimed |
| EP-4073516-A1 | METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS | Celcuity Inc. (US) | 2022-10-19 | — | — | EP | claimed |
| US-20220275330-A1 | COMPOSITIONS AND METHODS FOR DERIVATION OF TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY | 2022-09-01 | — | — | US | claimed |
| EP-3980085-B1 | COMPOSITIONS AND METHODS OF USING SAME FOR TISSUE REGENERATION | UNIV RAMOT (IL) | 2026-03-11 | — | — | EP | disclosed |
| US-12545890-B2 | Compositions and methods for derivation of trophoblast stem cells | NORTH CAROLINA STATE UNIVERSITY (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250144081-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-08 | — | — | US | disclosed |
| US-20250136932-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY | 2025-05-01 | — | — | US | disclosed |
| WO-2023150572-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-08-10 | — | — | WO | disclosed |
| WO-2023147001-A1 | COMPOSITIONS AND METHODS FOR CULTURING AND MAINTAINING TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20220412957-A1 | METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2022-12-29 | — | — | US | disclosed |
| EP-4073516-A1 | METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS | Celcuity Inc. (US) | 2022-10-19 | — | — | EP | disclosed |
| US-20220275330-A1 | COMPOSITIONS AND METHODS FOR DERIVATION OF TROPHOBLAST STEM CELLS | NORTH CAROLINA STATE UNIVERSITY | 2022-09-01 | — | — | US | disclosed |
| US-20220233578-A1 | COMPOSITIONS AND METHODS OF USING SAME FOR TISSUE REGENERATION | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-07-28 | — | — | US | disclosed |
| EP-3980085-A1 | COMPOSITIONS AND METHODS OF USING SAME FOR TISSUE REGENERATION | Ramot at Tel-Aviv University Ltd. (IL) | 2022-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545890-B2 | Compositions and methods for derivation of trophoblast stem cells | BMPR2, S1PR2, S1PR3 | S1PR1 6/4885S1PR3 3/4885DRD3 2654/4885 |
| US-20250144081-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | LIPC, PNLIP, LPL | S1PR1 7/4885S1PR3 13/4885DRD3 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.